Home  >  News
News
AstraZeneca receives US FDA approval for once-weekly Bydureon BCise injectable for patients with type-2 diabetes  October 24, 2017
 Back
 
IPJPI_150x60en_2017
acssymposium
cGMP_150x60
CPhI-WWW-150x60-stat-v1
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |